Commerce Bank lowered its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 3.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 3,328 shares of the company’s stock after selling 110 shares during the period. Commerce Bank’s holdings in U.S. Physical Therapy were worth $282,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy during the second quarter worth $28,000. Innealta Capital LLC purchased a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth about $30,000. Quest Partners LLC boosted its stake in shares of U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares in the last quarter. Quarry LP grew its position in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after acquiring an additional 478 shares during the period. Finally, Ridgewood Investments LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $51,000.
U.S. Physical Therapy Stock Performance
NYSE USPH opened at $97.08 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a 1-year low of $76.18 and a 1-year high of $113.63. The company has a market cap of $1.47 billion, a PE ratio of 104.89, a price-to-earnings-growth ratio of 4.43 and a beta of 1.38. The stock’s 50 day simple moving average is $85.80 and its 200-day simple moving average is $90.53.
U.S. Physical Therapy Announces Dividend
Analyst Ratings Changes
Several analysts have commented on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Bank of America reissued a “neutral” rating and issued a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st.
Check Out Our Latest Research Report on USPH
Insider Transactions at U.S. Physical Therapy
In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the transaction, the director now owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. The trade was a 51.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now directly owns 16,726 shares of the company’s stock, valued at $1,554,681.70. This trade represents a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,896 shares of company stock valued at $656,940 over the last 90 days. 1.70% of the stock is currently owned by corporate insiders.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
- Five stocks we like better than U.S. Physical Therapy
- With Risk Tolerance, One Size Does Not Fit All
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 REITs to Buy and Hold for the Long Term
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.